
Apixaban prescription beyond 90 days showed no difference in hospitalization risk for major bleeding.
Connor Iapoce is the assistant managing editor for HCPLive, after joining the MJH Life Sciences team in April 2021. He graduated from The College of New Jersey with a degree in Journalism and Professional Writing. He enjoys listening to records, going to the movies, and playing with his cat, Squish. You can reach him at [email protected].

Apixaban prescription beyond 90 days showed no difference in hospitalization risk for major bleeding.

The phase 3 trial was stopped following a formal interim assessment that met pre specified criteria for positive efficacy in patients with chronic kidney disease.

Data show LNCSBs as a substitute for sugar-sweetened beverages were associated with reduced body weight, BMI, percentage of body fat, and intrahepatocellular lipid.

Data show the absolute risk reductions of treatment with statins in terms of all-cause mortality, myocardial infarction, and stroke are modest compared with the relative risk reductions.

Clinical decision support intervention resulted in a rate of change in total modifiable CV risk that was 4% lower among intervention patients compared to control.

Patients with tachyarrhythmia or hypertension as their underlying trigger of type 2 MI had a lower mortality than patients with hypotension, hypoxemia, or anemia.

Patients who screened positive for depression had worse dry eye symptoms and overall signs but similar inflammatory markers compared to those negative for depression.

Children with strabismus had higher odds of having anxiety disorder, schizophrenia, bipolar disorder, and depressive disorder compared to those without eye diseases.

A look into the uptake of semaglutide, what the agent represents, and what is coming further in obesity management.

Levels of troponin after cardiac surgery associated with increased risk of death were higher than levels recommended to define periprocedural myocardial injury.

The heart transplant from a genetically modified pig was initially considered a success and represented new hope for Americans requiring transplants.

Pregnant women who experienced only spontaneous abortion or both spontaneous and induced abortion were at higher risk of developing gestational diabetes.

Lifestyle interventions had no statistically significant difference in reducing worsening glycemic status compared to usual care in women with gestational diabetes.

The use of GLP-1 receptor agonists was associated with lower all-cause mortality and lower sepsis- and infection-related mortality compared to DPP-4 inhibitors.

An increase in annual prevalence of beneficiaries with diabetes was observed in those who had ≥1 claim for DME (1.0% to 3.3%) and DME/VTDR (2.8% to 4.3%).

AGN-190584 showed superiority in efficacy over vehicle in mesopic DCNVA on day 30 with an acceptable safety profile for patients with presbyopia.

Dr. Granger discusses the current underuse of these agents and the steps cardiologists need to take to increase prescription rates and uptake for patients.

Dr. Pagidipati highlights her own approach to weight management, from lifestyle changes, diet, and medication to metabolic procedures.


African American individuals and Hispanic individuals were more likely than non-Hispanic White individuals to report not being able to afford medications.

The novel technology combines daily disposable contact lenses with ketotifen in a first in its new category approval.

The absolute survival rate observed for US patients with IHCA and COVID-19 was 11.9%.

General progress has been made in decreasing diabetes mortality at ages younger than 25 years, but challenges remain in low and low-middle SDI countries.

Pupillary dilation and manual eyelid lifting were shown to substantially increase visible retinal area and PLL-HMA detection using fully automated algorithms.

The FDA granted accelerated approval to the treatment of adults with intermediate or high-risk primary or second myelofibrosis.

The FDA asked the company to submit additional confirmatory evidence of effectiveness in the treatment of epidermolysis bullosa.

The complete response letter from the FDA cited a lack of effectiveness in slowing the loss of kidney function in patients with Alport syndrome.

The CDC has estimated at least 2.4 million flu illnesses, 23,000 hospitalizations, and 1,400 deaths from flu so far this season.

The annual rate of visual field loss was −0.15 dB for the slow OCTA progressors and −0.43 dB for the fast OCTA progressors.

More than 40% of community-acquired and 70% of hospital-acquired influenza inpatients experienced intrahospital bed transfers during their active infection period.